Glauconix BiosciencesTM can provide a wide range of custom designed studies incorporating biological and physiological analyses (e.g. Western Blot, PCR, ELISA, immunocytochemistry, perfusion studies, etc.) of post drug treated 3D tissue models. Furthermore, these studies can be prolonged for extended periods of treatment (>30 days) allowing for additional relevant clinical insights.  The high transfection efficiency achieved using Glauconix BiosciencesTM tissue models, permits experimental design of impactful target validation.  In addition to compound analysis or screening, these tissue models can also provide relevant insights into effects of glaucoma-related devices and procedures (e.g. implantable extended release devices, MIGS, trabeculoplasty, laser surgery, etc.).